Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients

Journal of Hypertension

Volumn 26, Issue 7, 2008, Pages 1353-1359

  Patel, Tejas V ^a   Williams, Gordon H ^a   Fisher, Naomi Deirdre L ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Ace inhibition; Age; Angiotensinogen; Hypertension; Pharmacogenomics; Renal blood flow

Indexed keywords

4 AMINOHIPPURIC ACID; ANGIOTENSIN II; ANGIOTENSINOGEN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; VASOCONSTRICTOR AGENT;

4 AMINOHIPPURIC ACID CLEARANCE; ADULT; AGE DETERMINATION; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DETERIORATION; ENZYME INHIBITION; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HIGH SODIUM INTAKE; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY PLASMA FLOW; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SINGLE DRUG DOSE; AGE; DRUG EFFECT; GENETIC POLYMORPHISM; GENETICS; KIDNEY; KIDNEY CIRCULATION; KIDNEY DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGE FACTORS; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINOGEN; CAPTOPRIL; FEMALE; GENOTYPE; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RENAL CIRCULATION; RENIN-ANGIOTENSIN SYSTEM; VASOCONSTRICTOR AGENTS;

EID: 54449086327     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282ffb417     Document Type: Article

References (35)

1. Ferrario CM. Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview. Drugs 2000; 39: Suppl 2:1-8.
2. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, et al. Intra-renal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 2004; 15:1805-1815.
3. Hollenberg NK, Chenitz WR, Adams DF, Williams GH. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man. J Clin Invest 1974; 54:34-42.
4. Hollenberg NK, Williams GH, Taub KJ, Ishikawa I, Brown C, Adams DF. Renal vascular response to interruption of the renin-angiotensin system in normal man. Kidney Int 1977; 12:285-293.
5. Fisher ND, Price DA, Litchfield WR, Williams GH, Hollenberg NK. Renal response to captopril reflects state of local renin system in healthy humans. Kidney Int 1999; 56:635-641.
6. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin MC, Skuppin J, et al. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertension 1996; 14:199-207.
7. Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of the different races. Gerontologia 1971; 17:87-97.
8. McLachlan MSF. The aging kidney. Lancet 1978; 2:143-145.
9. Kaplan C, Pasternack B, Shah H, Gallo G. Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80:227-234.
10. Wesson LG Jr. Renal hemodynamics in physiological states In: Physiology of the Human Kidney. New York: Grune and Stratton 1969. pp. 96-108.
11. Lindeman RD, Tobin JD, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 1985; 33:278-285.
12. Hollenberg NK, Williams GH. Abnormal renal function, sodium-volume homeostasis and renin system behavior in normal-renin essential hypertension: the evolution of the nonmodulator concept. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis and management, 2nd edition New York: Raven Press; 1998. pp. 1837-1856.
13. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556.
14. Raji A, Williams GH, Jeunemaitre X, Hopkins PN, Hunt SC, Hollenberg NK. Insulin resistance in hypertensives: effect of salt sensitivity, renin status and sodium intake. J Hypertens 2001; 19:99-105.
15. Fisher ND, Hurwitz S, Ferri C, Jeunemaitre X, Hollenberg NK, Williams GH. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension 1994; 34:388-394.
16. Jurinke C, van den Boom D, Cantor CR, Koster H. Automated genotyping using the DNA massarray technology. Methods Mol Biol 2002; 187:179-192.
17. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992; 20:1433.
18. Wang WY, Zee RY, Morris BJ. Association of angiotensin II type 1. receptor gene polymorphism with essential hypertension. Clin Genet 1997; 51:31-34.
19. Kitamura H, Moriyama T, Izumi M, Yokoyama K, Yamauchi A, Ueda N, et al. Angiotensin I-converting enzyme insertion/deletion polymorphism: potential significance in nephrology. Kidney Int 1996; 55:S101-S103.
20. Ingelfinger JR, Pratt RE, Ellison K, Dzau VJ. Sodium regulation of angiotensinogen mRNA expression in rat kidney cortex and medulla. JClin Invest 1986; 78:1311-1315.
21. Gaillard-Sanchez I, Mattei MG, Clauser E, Corvol P. Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1q42, the same region as human renin gene. Human Genet 1990; 84:341-343.
22. Borecki IB, Province MA, Ludwig EH, Ellison RC, Folsom AR, Heiss G, et al. Association of candidate loci angiotensinogen and angiotensin- converting enzyme with severe hypertension: the NHLBI Family Heart Study. Ann Epodemiol 1997; 7:13-21.
23. Tiret L, Blanc H, Ruidavet JB, Arveiler D, Luc G, Jeunemaitre X, et al. Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental historyofmyocardial infarction and stroke: the PEGASE study. Projet d'Etude des Genes de l'Hypertension Arterielle Severe a moderee Essentielle. J Hypertens 1998; 16:37-44.
24. Jeunemaitre X, Soubrier F, Kotelevtsey YV, Lifton RP, Williams CS, Charru A, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71.:169-180.
25. Fisher ND, Allan DR, Gaboury CL, Hollenberg NK. Intrarenal angiotensin II formation in humans. Evidence from renin inhibition. Hypertension 1995; 25:935-939.
26. Fisher ND, Allan D, Kifor I, Gaboury CL, Williams GH, Moore TJ, et al. Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans. Hypertension 1994; 23:44-51.
27. Epstein M. Effects ofaging on the kidney. Federation Proc 1979; 38:168-172.
28. Anderson S, Brenner BM. Effects of aging on the renal glomerulus. Am J Med 1986; 80:435-442.
29. Lindeman RD, Tobin JD, Shock NW. Hypertension and the kidney. Nephron 1987; 47. (Suppl 1):62-67.
30. Schmieder RE, Schachinger H, Messerli FH. Accelerated decline in renal perfusion with aging in essential hypertension. Hypertension 1994; 23:351-357.
31. Baylis C. Renal responses to acute angiotensin II inhibition and administered angiotensin II in the aging, conscious, chronically catheterized rat. Am J Kid Disease 1993; 22:842-850.
32. Inserra F, Romano LA, De Cavanagh EM, Ercole L, Ferder LF, Gmoez RA. Renal interstitial sclerosis in aging: effects of enalapril and nifedipine. J Am Soc Nephrol 1996; 7:676-680.
33. Ma LJ, Nakamura S, Aldigier JC, Rossini M, Yang H, Liang Z, et al. Regression of glmerulosclerosis with high-dose Angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1. J Am Soc Nephrol 2005; 16:966-976.
34. Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, et al. In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 2002; 39:838-843.
35. Redgrave J, Robinowe S, Hollenberg NK, Williams GH. Correction of abnormal renal blood flow response to angiotensin II and converting-enzyme inhibition in essential hypertensives. JClin Invest 1985; 75:1285-1290.